Effectiveness of percutaneous laser revascularization therapy for refractory angina

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 735-747

  McGillion, Michael ^a   Cook, Allison ^b   Charles Victor, J ^a   Carroll, Sandra ^b   Weston, Julie ^a   Teoh, Kevin ^c   Arthur, Heather M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Angina symptoms; Health related quality of life; Meta analysis; Percutaneous laser revascularization; Refractory angina

Indexed keywords

ANGINA PECTORIS; CLINICAL EFFECTIVENESS; CORONARY ARTERY DISEASE; EXERCISE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HEART DISEASE; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS LASER REVASCULARIZATION THERAPY; PHYSICAL DISABILITY; QUALITY OF LIFE; REFRACTORY ANGINA; REVIEW; SECONDARY ANALYSIS; THORAX PAIN; CHI SQUARE DISTRIBUTION; EPIDEMIOLOGY; HEART MUSCLE REVASCULARIZATION; KAPLAN MEIER METHOD; METHODOLOGY; RISK; TIME; TREATMENT OUTCOME;

ANGINA PECTORIS; BIAS (EPIDEMIOLOGY); CHI-SQUARE DISTRIBUTION; HUMANS; KAPLAN-MEIER ESTIMATE; ODDS RATIO; QUALITY OF LIFE; TIME FACTORS; TRANSMYOCARDIAL LASER REVASCULARIZATION; TREATMENT OUTCOME;

EID: 79952062133     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S8222     Document Type: Review

References (42)

1. Mannheimer C, Camici P, Chester MR, et al. The problem of chronic refractory angina; report from the ESC Joint Study Group on the treatment of refractory angina. Eur Heart J. 2002;23:355-370.
2. Bhatt AB, Stone PH. Current strategies for the prevention of angina in patients with stable coronary artery disease. Curr Opin Card. 2006; 21:492-502.
3. McGillion M, L'Allier P, Arthur H, et al. Recommendations for advancing the care of Canadians living with refractory angina pectoris: A Canadian Cardiovascular Society position statement. Can J Cardiol. 2009; 25:399-401.
4. Henry TD, Satran D, Johnson RK, et al. Natural history of patients with refractory angina. J Am Coll Cardiol. 2006;47:231A.
5. Brorsson B, Bernstein SJ, Brook RH, Werko L. Quality of life of patients with chronic stable angina before and 4 years after coronary artery revascularization compared with a normal population. Heart. 2002; 87:140-145.
6. Erixson G, Jerlock M, Dahlberg K. Experiences of living with angina pectoris. Nurs Sci Res Nordic Countries. 1997;17:34-38.
7. Andrell P, Ekre O, Wahborg P, Eliasson T, Mannheimer C. Quality of life in patients with refractory angina pectoris. International Association for the Study of Pain 11th World Congress on Pain [abstract]; 2005 Aug 21-26; Sydney, Australia: IASP Press; 2005. p. 200.
8. McGillion M, Watt-Watson J, LeFort S, Stevens B. Positive shifts in the perceived meaning of cardiac pain following a psychoeducation for chronic stable angina. Can J Nurs Res. 2007;39:48-65.
9. Chow C-M, Donovan L, Manuel D, et al. Regional variation in selfreported heart disease prevalence in Canada. Can J Cardiol. 2005; 21:1265-1271.
10. Thadani U. Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris. Coron Artery Dis. 2004; 15 Suppl 1:S1-S4.
11. Oesterle SN. Laser percutaneous myocardial revascularization. Am J Cardiol. 1999;83:46-52.
12. Oesterle SN, Sanborn TA, Ali N, et al. Percutaneous transmyocardial laser revascularization for severe angina: The PACIFIC randomized trial. Lancet. 2000;356:1705-1710.
13. Salem M, Rotevatn S, Stavnes S, et al. Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris. Am J Cardiol. 2004;93:1086-1091.
14. Briones E, Lacalle JR, Marin I. Transmyocardial laser revascularization versus medical therapy for refractory angina. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD003712. DOI:10.1002/14651858.CD003712.pub2.
15. Kohmoto T, Fisher PE, Gu A, et al. Physiology, histology and 2-week morphology of acute transmyocardial laser channels made with a CO2 laser. Ann Thorac Surg. 1997;63:1275-1283.
16. Gassler N, Wintzer HO, Stubbe HM, et al. Transmyocardial laser revascularization. Histological features in human nonresponder myocardium. Circulation. 1997;95:371-375.
17. Burkoff D, Fisher PE, Apefelbaum M, et al. Histologic appearance of transmyocardial laser channels after 41/2 weeks. Ann Thorac Surg. 1996;62:1501-1508.
18. Mueller XM, Tevaearai HH, Genton CY, et al. Transmyocardial laser revascularization in acutely ischaemic myocardium. Eur J Cardiothorac Surg. 1998;13:170-175.
19. Mirhoseini M, Fisher J, Clayton M. Myocardial revascularization by laser: a clinical report. Lasers Surg Med. 1983;3:241-245.
20. Mukherjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis- how many patients might be eligible? Am J Cardiol. 1999:84:589-600.
21. Weimer M, Butz T, Weilepp J, Fassbender, D, Buchert W. Improvement of myocardial perfusion detected by positron emission tomography in patients with end-stage coronary artery disease treated with percutaneous myocardial laser revascularization (abstr).Circulation. 2001;104 suppl 2:11-445.
22. Rimoldi O, Burns SM, Rosen SD, et al. Measurement of myocardial blood flow with positron emission tomography before and after transmyocardial laser revascularization. Circulation. 1999;100:2134-2138.
23. Burns SM, Brown S, White CA, et al. Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization. Am J Cardiol. 2001;87:861-867.
24. Guzetti S, Colombo A, Piccaluga E, et al. Absence of clinical signs of denervation after percutaneous myocardial laser revascularization. Int J Cardiol. 203:91:129-135.
25. Al-Sheikh T, Allen KB, Straka SP, et al. Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation. 1999; 100:135-140.
26. Myers J, Osterle SN, Jones J, et al. Do transmyocardial and percuatneous laser revascularization induce silent ischemia? An assessment by exercise testing. Am Heart J. 2002;143:1052-1057.
27. Beek J, van der Sloot JAP, Huikeshoven M, et al. Cardiac denervation after clinical transmyocardial laser revasacularization: Short-term and long-term iodine 123-labeled meta-iodobenzylguanide scintigraphic evidence. J Thorac Cardiovasc Surg. 2004;127:517-524.
28. Leon MB, Kornowski R, Downey E, et al. A blinded-randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol. 2005;46:1812-1819.
29. Whitlow, Pl, DeMaio SJ, Perin EC, et al. One-year results of percutaneous myocardial revascularization for refractory angina pectoris. Am J Cardiol. 2003;91:1342-1346.
30. Gray T, Burns SM, Clarke SC, et al. Percutaneous myocardial laser revascularization in patients with refractory angina pectoris. Am J Cardiol. 2003;91:661-666.
31. Salem M, Rotevatn S, Nordrehaug JE. Long-term results following percutaneous myocardial laser therapy. Coron Artery Dis. 2006;17: 385-390.
32. McNab D, Khan SN, Sharples LD, et al. An open label, single centre, randomized trial of spinal cord stimulation vs percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial. Eur J Cardiol. 2006;27:1048-1053.
33. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochranehandbook.org.
34. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Res Methodol. 2005;5:13 doi:10.1186/1471-2288-5-13.
35. Tomlinson G, Beyene J. [P148] Imputing summary statistics for metaanalysis of continuous data. 12th Cochrane Colloquium, Ottawa, 2-6 Oct 2004.
36. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Earlbaum Associates;1988.
37. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ. 2001;323;42-46.
38. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
39. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
40. Rucker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I2 in assessing heterogeneity may mislead. BMC Medical Res Methodol. 2008;8:79.
41. Stone GW, Teirstein PS, Rubenstein R, et al. A prospective, multicentre, randomized trial of percutaneous tranmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. J Am Coll Cardiol. 2002;39:1581-1587.
42. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25:333-341.